1. Stocks
  2. Gland Pharma Ltd.
  3. Swot
Gland Pharma Ltd. SWOT Analysis: Strengths, Weakness, Opportunity, and Threats
Rising Net Cash Flow and Cash from Operating activity 375.3% returns for Nifty 500 over 5.9 years
Effectively using its capital to generate profit - RoCE improving in last 2 years -16.8% returns for Nifty 500 over 1.9 years
Effectively using Shareholders fund - Return on equity (ROE) improving since last 2 year
Efficient in managing Assets to generate Profits - ROA improving since last 2 year
Company with Low Debt
Company able to generate Net Cash - Improving Net Cash Flow for last 2 years
Annual Net Profits improving for last 2 years
Company with Zero Promoter Pledge
Near 52 Week High
Companies with growing costs YoY for long term projects
Bearish Stocks - Stocks with Medium to Low Trendlyne Momentum Score 86.4% returns for Nifty 500 over 4.5 years
Hanging Man (Bearish Reversal)
RSI indicating price strength
Stocks near 52 Week High with Significant Volumes
Stocks with Expensive Valuations according to the Trendlyne Valuation Score 177.2% returns for Nifty 500 over 4.5 years
Stocks with high PE (PE > 40)
Bullish or Bearish Candlestick Strength - Indices
Top Gainers